Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-free anesthesia with esketamine + dexmedetomidine + sevoflurane for small and medium-sized surgery
ChiCTR2300069061Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine, dexmedetomidine and sevoflurane in perioperative pain, postoperative nausea and vomiting (PONV) and respiratory failure (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Incidence of postoperative nausea and vomiting (PONV) and rescue treatment, Postoperative respiratory function and 1 more. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
esketaminedexmedetomidinesevoflurane
03
Conditions
perioperative painpostoperative nausea and vomiting (PONV)respiratory failure
Beyond the preview
Go deeper on ChiCTR2300069061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069061.